ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

AAMI and FDA Co-Sponsor Medtech Conference, ‘AAMI and FDA neXus'

Arlington, VA, Jan. 08, 2024 (GLOBE NEWSWIRE) -- The Association for the Advancement of Medical Instrumentation (AAMI) is delighted to welcome the U.S. Food and Drug Administration as an official co-sponsor of its upcoming medical device standards conference, AAMI and FDA neXus 2024. The conference will feature a wealth of FDA experts alongside industry members and will focus on the latest information on medical device regulations and standards.

AAMI and FDA neXus will be held from February 20 to 23, 2024, at the Omni Shoreham Hotel in Washington, D.C. Jeffrey Shuren M.D., director of the FDA’s Center for Devices and Radiological Health, will deliver a keynote on February 20. FDA experts will also present on the following topics:

  • The FDA’s new QSR and transition to ISO 13485, presented by FDA’s Keisha Thomas, supervisory consumer safety, and Kimberly Lewandoski-Walker, regulatory officer.  
  • Real-world evidence and medical device safety, presented by Daniel Caños, director of the Office of Clinical Evidence and Analysis at CDRH.
  • FDA’s collaboration with IMDRF, presented by Ken Cavanaugh, deputy office director of the Office of Health Technology.
  • The FDA case for quality, delivered by Francisco Vicenty, FDA consumer safety officer.
  • Total product lifecycle, presented by Linda Ricci, deputy director of the Office of Strategic Partnerships and Technology Innovation and Tammy Beckham, associate office director.
  • Additional FDA speakers on pulse oximeters, FDA’s health equity priorities, the ASCA program, biocompatibility, eSTAR, and more.

The conference also features educational courses on industrial sterilization, quality systems, human factors, and other topics. Industry experts are also scheduled to speak on topics like sterile processing, industry standards and other technical areas. Industry speakers include:

  • University of Utah instructor David Classen M.D., on AI implementation.
  • Global perspectives on ethylene oxide sterilization, presented by Brian McEvoy of STERIS and Molly Story of Human Spectrum Design.
  • Development of IFUs for sterilization, presented by Nupur Jain of Intuitive Surgical and Ralph Basile of Healthmark Industries.
  • Cleaning validation processes, presented by Terra Kremer, director of microbiological quality at Johnson & Johnson.
  • Other sessions on international standardization, AI/ML, and forthcoming guidance documents.

The AAMI and FDA neXus is the newest iteration of the International Standards Conference (ISC), a must attend for medical device regulators and industry members since 1991. AAMI’s Robert Burroughs, chief learning and development officer said, “We’re excited to bring the same focus from ISC to AAMI Nexus but will also cover material on standards application. Development, adoption, and now application of standards, neXus covers it all.”

Those interested in attending can find registration for the AAMI FDA neXus here. Press passes are available upon request. Questions? Reach out to aamievents@aami.org for question about registration, sessions, and course offerings, and dvisnovsky@aami.org regarding press access.


Primary Logo

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.